SLN
Silence Therapeutics Plc
Company Overview
| Mkt Cap | $342.11M | Price | $7.16 |
| Volume | 93.93K | Change | -2.05% |
| P/E Ratio | -7.9 | Open | $7.15 |
| Revenue | $25.4M | Prev Close | $7.31 |
| Net Income | $-43.3M | 52W Range | $1.97 - $18.29 |
| Div Yield | N/A | Target | $30.50 |
| Overall | 66 | Value | -- |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailySilence Therapeutics Plc (SLN) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $7.16 with a market capitalization of $342.11 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SLN with a volume of 94K shares. The stock opened down 2.19% from yesterday's close of $7.31. Current analyst estimates project earnings of $-1.53 per share for this year, with next year targeting $-1.22.
SLN demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for SLN include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 326.0%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:19 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SLN | $7.16 | -2.1% | 93.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Silence Therapeutics Plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW